These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 32970164)

  • 1. Long-term results of robotic radiosurgery for non brachytherapy patients with cervical cancer.
    Morgenthaler J; Köhler C; Budach V; Sehouli J; Stromberger C; Besserer A; Trommer M; Baues C; Marnitz S
    Strahlenther Onkol; 2021 Jun; 197(6):474-486. PubMed ID: 32970164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is SBRT Boost Feasible for PET Positive Lymph Nodes for Cervical Cancer? Evaluation using Tumor Control Probability and QUANTEC Criteria.
    Snyder JE; Willett AB; Sun W; Kim Y
    Pract Radiat Oncol; 2019 Mar; 9(2):e156-e163. PubMed ID: 30415074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brachytherapy-emulating robotic radiosurgery in patients with cervical carcinoma.
    Marnitz S; Köhler C; Budach V; Neumann O; Kluge A; Wlodarczyk W; Jahn U; Gebauer B; Kufeld M
    Radiat Oncol; 2013 May; 8():109. PubMed ID: 23638755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive stereotactic ablative boost in patients with locally advanced cervical cancer.
    Dalwadi S; Echeverria A; Jhaveri P; Bui T; Waheed N; Tran D; Bonnen M; Ludwig M
    Int J Gynecol Cancer; 2020 Nov; 30(11):1684-1688. PubMed ID: 32636273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.
    Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM
    Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity modulated radiation therapy boost in locally-advanced cervical cancer in the absence of brachytherapy.
    Lazzari R; Riva G; Augugliaro M; Vavassori A; Dicuonzo S; Cattani F; Comi S; Colombo N; Jereczek-Fossa BA
    Int J Gynecol Cancer; 2020 May; 30(5):607-612. PubMed ID: 32188626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse Planned High-Dose-Rate Brachytherapy for Locoregionally Advanced Cervical Cancer: 4-Year Outcomes.
    Tinkle CL; Weinberg V; Chen LM; Littell R; Cunha JAM; Sethi RA; Chan JK; Hsu IC
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1093-1100. PubMed ID: 26194683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
    Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
    Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose escalation with stereotactic body radiotherapy for cervical cancer treatment.
    Turna M; Rzazade R; Küçükmorkoç E; Küçük N; Canoğlu MD; Çağlar HB
    BMC Cancer; 2024 Oct; 24(1):1281. PubMed ID: 39407149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage robotic SBRT for local prostate cancer recurrence after radiotherapy: preliminary results of the Oscar Lambret Center.
    Leroy T; Lacornerie T; Bogart E; Nickers P; Lartigau E; Pasquier D
    Radiat Oncol; 2017 Jun; 12(1):95. PubMed ID: 28599663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible.
    Lee TH; Song C; Kim IA; Kim JS; Kim YB; Kim K; No JH; Suh DH; Chung JB; Eom KY
    Radiat Oncol; 2021 Aug; 16(1):148. PubMed ID: 34384450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase II Trial of Stereotactic Ablative Radiation Therapy as a Boost for Locally Advanced Cervical Cancer.
    Albuquerque K; Tumati V; Lea J; Ahn C; Richardson D; Miller D; Timmerman R
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):464-471. PubMed ID: 31697990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy.
    Kelley KD; Benninghoff DL; Stein JS; Li JZ; Byrnes RT; Potters L; Knisely JP; Zinkin HD
    Radiat Oncol; 2015 May; 10():120. PubMed ID: 26018408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Californium-252 neutron brachytherapy combined with external pelvic radiotherapy plus concurrent chemotherapy for cervical cancer: a retrospective clinical study.
    Qian S; Ye L; Tian YH; Wang LG; Huang ZP; Li F; Hou B; Song N; Chen J; Liu Y; Liu X; Zhou T
    Chin J Cancer; 2017 Feb; 36(1):24. PubMed ID: 28245859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer.
    Contreras J; Srivastava A; Chundury A; Schwarz JK; Markovina S; Thaker PH; Massad LS; Mutch DG; Powell MA; Grigsby PW; Lin AJ
    Int J Gynecol Cancer; 2020 Aug; 30(8):1157-1161. PubMed ID: 32527770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining the recommended dose of stereotactic body radiotherapy boost in patients with cervical cancer who are unsuitable for intracavitary brachytherapy: a phase I dose-escalation study.
    Ito K; Kito S; Nakajima Y; Shimizuguchi T; Ogawa H; Nihei K; Tanaka H; Kino N; Yasugi T; Karasawa K
    Jpn J Clin Oncol; 2019 Sep; 49(9):856-861. PubMed ID: 31112278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-Dose-Rate Brachytherapy Boosting Concurrent Chemoradiation as a Definitive Treatment Modality for Cervical Cancer: Long-term Clinical Results of Outcomes and Associated Toxicity.
    Refaat T; Donnelly ED; Gentile M; Novak C; Yuan Y; Khedr GA; Helenowksi I; Lurain J; Schink J; Rademaker A; Sathiaseelan V; Strauss JB; Small W
    Am J Clin Oncol; 2016 Apr; 39(2):196-203. PubMed ID: 24487420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose escalation with stereotactic body radiation therapy boost for locally advanced non small cell lung cancer.
    Karam SD; Horne ZD; Hong RL; McRae D; Duhamel D; Nasr NM
    Radiat Oncol; 2013 Jul; 8():179. PubMed ID: 23842112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.